CORMEDIX INC. (CRMD)

Healthcare · Pharmaceuticals · Price $8.30
Updated: Sep 1, 2026
Net Income (TTM)
$187.2M
Trailing 12 Months
Growth Rate
13.40%
Log-Linear Regression (16Q)
Price/Earnings
3.8x
Valuation Multiple
EPS (Diluted)
$2.18
Net Income / Shares
Net Margin
40.49%
Profitability

📈 Net Income History (16 Quarters)

🧮 CRMD Net Income Breakdown

Net Income = Revenue - All Expenses - Taxes - Interest
Revenue (Top Line) $462.2M
Less: Cost of Revenue → Gross Profit $382.6M
Less: Operating Expenses → Operating Income $217.0M
Less: Interest Expense $2.8M
Less: Income Tax Expense $16.8M
Equals: Net Income (Bottom Line) $187.2M

Understanding Net Income

Net income, also called the "bottom line" or net profit, is the money a company keeps after paying all expenses including cost of goods, operating costs, interest, and taxes. For CRMD, the trailing twelve month net income is $187.2M.

Why Net Income Matters

Net income is the ultimate measure of accounting profitability. It determines earnings per share (EPS), affects stock valuations through the P/E ratio, and represents the theoretical amount available to shareholders. However, net income can be influenced by accounting choices, which is why value investors often look at cash flow metrics alongside it.

CRMD's net income growth rate of 13.40% (based on log-linear regression of 16 quarters) indicates strong profit growth above market averages.

Net Income vs Cash Flow Metrics

Free Cash Flow: $194.7M →

Actual cash generated after capital expenditures. FCF often differs from net income due to depreciation, working capital changes, and capex timing.

Owner Earnings: $194.7M →

Buffett's preferred metric that adds back depreciation but subtracts maintenance capex. Often considered more accurate than net income.

EPS (Diluted): $2.18 →

Net income divided by diluted shares outstanding. The primary driver of the P/E ratio used in valuations.

Revenue: $462.2M →

The top line that net income is derived from. Net margin shows what percentage of revenue becomes profit.

P/E Ratio Analysis

CRMD's P/E ratio of 3.8x means investors pay $3.81 for every $1 of annual earnings. A P/E below 10 is generally considered "value" territory.

Net Margin: Profitability Efficiency

Net margin of 40.49% shows what percentage of CRMD's revenue converts to profit after all costs. Net margins above 20% are excellent and indicate strong pricing power or asset-light business models.

Summary: CRMD Net Income Trend

CORMEDIX INC. (CRMD) has a net margin of 40.49%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 13.40% annually — above the 10% threshold Zyberno considers healthy growth above market averages. For complete financial analysis, view the full CRMD stock report on Zyberno.

Frequently Asked Questions

What is CRMD's current net income?

CORMEDIX INC.'s TTM net income is $187.2M, growing at 13.40% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

Is CRMD's net income growing?

CORMEDIX INC. (CRMD) has a net margin of 40.49%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 13.40% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

What is CRMD's net profit margin?

CORMEDIX INC. (CRMD) has a net margin of 40.49%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 13.40% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

What is CRMD's P/E ratio?

CRMD's P/E ratio is 3.8x, meaning the market values the company at 3.8 times its annual earnings.

How does net income differ from free cash flow?

Net income is an accounting measure that includes non-cash items like depreciation, while free cash flow shows actual cash generated. CRMD's net income is $187.2M versus free cash flow of $194.7M. Large differences often indicate significant capital expenditures or working capital changes.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
$77.24
🛡️
Margin of Safety
Valuation Gap
89.3%
🎯
Expected Return
Projected Annual
87.5%
Click any metric for full methodology and detailed analysis

📊 Full CRMD Stock Report

See CRMD's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 CRMD Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 CRMD Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 CRMD Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 CRMD Earnings Surprise (SUE)

See whether CRMD is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 CRMD Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 CRMD Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 CRMD Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 CRMD Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full CRMD Report Find More Quality Stocks
Scroll to Top